US · FORA
Forian Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Newtown, PA 18940
- Website
- forian.com
Price · as of 2024-12-31
$2.16
Market cap 64.63M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $47.61 | +2,109.28% |
| Intrinsic Value(DCF) | $38.69 | +1,695.36% |
| Graham-Dodd Method(GD) | $0.36 | -83.29% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $12.46 | ||||
| 2021 | $5.78 | $371.63 | $711,411.02 | $0.00 | $0.00 |
| 2022 | $3.51 | $34.41 | $0.00 | $0.00 | $0.00 |
| 2023 | $2.87 | $60.63 | $88.21 | $2.60 | $11.04 |
| 2024 | $2.11 | $47.61 | $0.76 | $0.36 | $0.00 |
AI valuation
Our deep-learning model estimates Forian Inc.'s (FORA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $47.61
- Current price
- $2.16
- AI upside
- +2,109.28%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$38.69
+1,695.36% upside
Graham-Dodd
$0.36
-83.29% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| FORA | Forian Inc. | $2.16 | 64.63M | +2,109% | +1,695% | -83% | — | -17.38 | 2.18 | 3.25 | -12.78 | — | 2.27 | 63.61% | -34.67% | -18.71% | -13.05% | -342.94% | -6.98% | 0.22 | -9.86 | 2.68 | 2.51 | -0.73 | -13333.00% | -160.00% | -5671.00% | 0.43% | 0.02 | 13.88% | 0.00% | 0.00% | 23.07% | -5.32 | 131.52 | 1.85 | 1.46 |
| AMWL | American Well Corporation | $5.70 | 94.35M | +398% | -51% | — | — | -0.89 | 0.36 | 0.34 | 1.30 | — | 0.50 | 53.29% | -42.22% | -38.38% | -35.42% | -147.82% | -25.19% | 0.02 | — | 3.37 | 3.17 | 2.49 | -5706.00% | -198.00% | -5372.00% | -77.57% | -0.90 | -92.64% | 0.00% | 0.00% | 0.00% | 0.88 | 1.41 | -0.37 | -7.90 |
| ASRT | Assertio Holdings, Inc. | $11.66 | 74.82M | +1,017% | +6,046% | -82% | +159% | -3.44 | 0.61 | 0.59 | 2.82 | — | 1.83 | 68.61% | -19.59% | -17.27% | -16.66% | -29.57% | -7.56% | 0.33 | -8.05 | 1.77 | 1.34 | -2.01 | -9507.00% | -1783.00% | -4608.00% | 35.54% | 0.23 | 31.91% | 0.00% | 0.00% | 0.47% | -0.59 | 0.55 | 0.12 | -2.51 |
| BEAT | HeartBeam, Inc. | $1.51 | 52.01M | — | — | — | — | -3.00 | 35.28 | — | -2.82 | -216.03 | 35.28 | 0.00% | — | — | -221.11% | 4079.38% | -190.60% | 0.00 | — | 1.71 | 1.47 | 0.12 | 139.00% | — | 1881.00% | -25.14% | -8.92 | 3009.64% | 0.00% | 0.00% | 0.00% | -2.81 | -3.82 | — | -22.07 |
| GEG | Great Elm Group, Inc. | $2.05 | 56.61M | +3,968% | +14% | +137% | — | 4.89 | 1.08 | 4.66 | 1.39 | — | 1.31 | -0.66% | -49.05% | 79.01% | 23.38% | -51.59% | 10.56% | 0.89 | -1.93 | 14.34 | 11.85 | 1.33 | -81274.00% | -851.00% | -4210.00% | -11.85% | -0.94 | -58.38% | 0.00% | 0.00% | 9.52% | -3.64 | -3.24 | 1.79 | -27.91 |
| LUNG | Pulmonx Corporation | $1.58 | 65.17M | +1,684% | +90% | — | — | -5.19 | 3.41 | 3.49 | -4.87 | — | 3.50 | 74.00% | -68.87% | -67.30% | -55.25% | -138.32% | -33.11% | 0.66 | -16.45 | 5.58 | 4.72 | 0.28 | -1000.00% | 2201.00% | -1414.00% | -11.27% | -1.29 | -79.07% | 0.00% | 0.00% | 0.00% | -4.29 | -7.50 | 2.95 | -1.57 |
| NTRB | Nutriband Inc. | $4.44 | 54.06M | +340% | -57% | — | — | -4.78 | 7.79 | 23.39 | -4.51 | -10.98 | 11.26 | 32.68% | -312.62% | -489.86% | -162.94% | -157.60% | -139.89% | 0.03 | -312.51 | 4.88 | 4.46 | 0.41 | 4348.00% | 262.00% | 3184.00% | -9.43% | -4.71 | -111.17% | 0.00% | 0.00% | 8.03% | -6.87 | -9.73 | 21.47 | 19.59 |
| ONMD | OneMedNet Corporation | $1.02 | 33.44M | +2,413% | -71% | — | +864% | -2.08 | -1.32 | 32.79 | -2.70 | — | -1.32 | -43.70% | -1493.78% | -1575.27% | 70.32% | 106.64% | -483.48% | -0.55 | -65.34 | 0.19 | 0.17 | -0.87 | -9245.00% | -3702.00% | 4548.00% | -33.36% | -0.36 | 78.10% | 0.00% | 0.00% | 0.95% | -2.79 | -3.81 | 41.72 | -50.87 |
| TCRX | TScan Therapeutics, Inc. | $1.06 | 60.15M | +2,649% | +18% | — | +7,924% | -1.74 | 0.92 | 78.74 | -0.24 | — | 0.92 | 100.00% | -4787.68% | -4527.66% | -65.08% | -271.01% | -39.64% | 0.40 | -36.91 | 8.14 | 8.07 | 0.68 | -1618.00% | -8662.00% | 7774.00% | -51.70% | -3.08 | -230.45% | 0.00% | 0.00% | 18.21% | -0.22 | -0.25 | 10.30 | -0.75 |
| XBIT | XBiotech Inc. | $2.26 | 68.9M | — | — | — | — | -2.57 | 0.54 | — | 1.76 | -4.62 | 0.54 | 0.00% | — | — | -19.21% | -219.51% | -18.10% | 0.06 | -52.63 | 11.56 | 11.49 | 4.51 | 5556.00% | — | 6905.00% | -32.59% | -2.05 | -166.91% | 0.00% | 0.00% | 0.00% | 1.49 | 1.97 | — | 3.15 |
About Forian Inc.
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
- CEO
- Max C. Wygod
- Employees
- 47
- Beta
- 1.03
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($38.69 ÷ $2.16) − 1 = +1,695.36% (DCF, example).